(1)
Yıldız Pehlivan, D.; Yıldız, H.; Kaya, G. Dapagliflozin Modulates MicroRNA Expression in Type 2 Diabetes Patients With Diabetic Nephropathy: A Retrospective Study. Eur J Ther 2025, 31, 1-10.